Caring Brands (CABR) Registration Filing summary

Company overview and business model

• Operates as a wellness consumer products company offering OTC and cosmetic products for skin and hair conditions, including treatments for psoriasis, vitiligo, eczema, and hair loss, as well as suncare and women's wellness products.

• Focuses on clinically validated, patent-protected formulations with established mechanisms of action and commercial stability.

• Products are sold through e-commerce, licensing, and distribution agreements, with manufacturing in India and the U.S.

• Recent separation from Safety Shot, Inc. to operate as a standalone public company, with all related assets and liabilities transferred.

Financial performance and metrics

• Reported nominal revenues and net losses of $1,199,353 for the six months ended June 30, 2025, and $1,517,431 for the year ended December 31, 2024.

• Cash and cash equivalents were $73,893 as of June 30, 2025, and $468,998 as of December 31, 2024.

• Operating expenses for the six months ended June 30, 2025, were $1,200,582, primarily from stock-based compensation, amortization, professional fees, and salaries.

• Accumulated deficit and recurring losses raise substantial doubt about ability to continue as a going concern.

Use of proceeds and capital allocation

• Net proceeds of approximately $3.2 million from the IPO are allocated to product development, manufacturing, marketing, clinical testing, repayment of related party loans, legal and compliance, and general working capital.

• Proceeds are expected to fund operations for about 12 months under the current business plan.

• Key product development milestones include relaunches and reformulations for Photocil, Hair Enzyme Booster, CB-101, and No Stingz, with targeted U.S. launches in 2026.